Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 5/20 | 0.44 |
| ▸ | CES1 | P23141 | 6/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.40 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PLK1 | P53350 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7892788 | 0.93 | PTGS2 (0.41) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL29191779 | 0.81 | PLA2G4B (0.41) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL15457916 | 0.80 | MAPT (0.58) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL28437029 | 0.80 | MAPT (0.58) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL6465332 | 0.80 | MAPT (0.58) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL14998165 | 0.80 | MAPT (0.58) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL29191780 | 0.79 | MGLL (0.48) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL2522380 | 0.78 | ALDH1A1 (0.58) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL7900084 | 0.77 | MAOA (0.42) | MAPT | |
| SCHEMBL465114 | 0.77 | CES2 (0.58) | MAPTCES2CES1NAAAPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114334274-B | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-114334274-B | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117645724-A | Main chain polymer and preparation method and application thereof | 中山大学 | 2024-03-05 | — | — | CN | disclosed |
| CN-114334274-A | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20170172855-A1 | Compositions With Controlled Network Structure | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-22 | — | — | US | disclosed |
| US-20170172855-A1 | Compositions With Controlled Network Structure | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-22 | — | — | US | disclosed |
| US-20170156993-A1 | DENTAL MATERIALS WITH DEBONDING-ON-DEMAND PROPERTIES | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-08 | — | — | US | disclosed |
| US-20170156993-A1 | DENTAL MATERIALS WITH DEBONDING-ON-DEMAND PROPERTIES | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-08 | — | — | US | disclosed |
| WO-2016005534-A1 | COMPOSITES HAVING A CONTROLLED NETWORK STRUCTURE | IVOCLAR VIVADENT AG (LI) | 2016-01-14 | — | — | WO | disclosed |
| WO-2016005540-A1 | DENTAL MATERIALS HAVING DEBONDING-ON-DEMAND PROPERTIES | IVOCLAR VIVADENT AG (LI) | 2016-01-14 | — | — | WO | disclosed |
| EP-2965741-A1 | Composites with controlled network structure | Ivoclar Vivadent AG (LI) | 2016-01-13 | — | — | EP | disclosed |
| EP-2965740-A1 | Dental materials with debonding on demand properties | Ivoclar Vivadent AG (LI) | 2016-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170172855-A1 | Compositions With Controlled Network Structure | NCLN, RAD51, SMCHD1 | GMNN 18/4885TP53 3944/4885POLB 429/4885 |
| US-20170156993-A1 | DENTAL MATERIALS WITH DEBONDING-ON-DEMAND PROPERTIES | DCLRE1A, RAD51, TERB1 | GMNN 555/4885TP53 4071/4885POLB 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.